Clene (NASDAQ: CLNN) CEO and CFO Present Corporate Updates and Future Plans at 72nd Emerging Growth Conference
Clene (NASDAQ: CLNN) CEO and CFO provide corporate updates and future plans at Emerging Growth Conference, highlighting progress in developing treatments for ALS and MS.
This news matters as it provides insight into Clene's progress in developing treatments for neurodegenerative diseases, potentially attracting investors and offering hope for patients with ALS and MS.